Skip to main content
ACS Omega logoLink to ACS Omega
. 2026 Jan 6;11(2):3665. doi: 10.1021/acsomega.5c13443

Retraction of “Appraisal of the Antiarthritic Potential of Prazosin via Inhibition of Proinflammatory Cytokine TNF-α: A Key Player in Rheumatoid Arthritis”

Sumera Qasim, Alamgeer, Muhammad Saleem, Nasser Hadal Alotaibi, Syed Nasir Abbas Bukhari, Khalid Saad Alharbi, Hafiz Muhammad Irfan, Rukhsana Anwar
PMCID: PMC12824955  PMID: 41585672

The Editor retracts “Appraisal of the Antiarthritic Potential of Prazosin via Inhibition of Proinflammatory Cytokine TNF-α: A Key Player in Rheumatoid Arthritis” (DOI: 10.1021/acsomega.0c05698) due to inconsistencies in the raw data of Table 1, the histological image in Figure 4d (identified as prazosin-treated) was found to be a duplication to Figure 4c (identified as amlodipine-treated) in 10.1007/s10787-020-00692-9, and the radiographic image in Figure 4b (normal control) was found to be a duplication to Figure 3c (piroxicam-treated) in 10.1021/acsomega.0c05054. In addition, the controls were reused across these three experiments, which raises concerns about proper experimental set up and therefore the reliability of the results presented. As such, the article is being retracted.

The original article was published on January 15, 2021, and retracted on January 6, 2026.


Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES